Bullish signal on daily chart
Meeting Agenda: Audited Results & Final Dividend. Please add to watchlist to track closely.
Potential
Upside
1 Year
Target
BUY
Mean Recos by
3 Analysts
/10
Stock Score
Earnings | |
Fundamentals | |
Relative Valuation | |
Risk | |
Price Momentum |
Meeting Agenda: Audited Results & Final Dividend. Please add to watchlist to track closely.
Company has spent 1.27% of its operating revenues towards interest expenses and 9.28% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
White Marubozu(s) was formed for Jubilant Ingrevia
Stock gave a 3 year return of 64.42% as compared to Nifty Midcap 100 which gave a return of 93.2%. (as of last trading session)
Jubilant Ingrevia Ltd. share price moved up by 4.31% from its previous close of Rs 692.95. Jubilant Ingrevia Ltd. stock last traded price is 722.75
Share Price | Value |
---|---|
Today/Current/Last | 722.75 |
Previous Day | 692.95 |
PE Ratio (x) | 55.84 | ||||||||||
EPS - TTM (₹) | 12.96 | ||||||||||
MCap (₹ Cr.) | 11,523.99 | ||||||||||
Sectoral MCap Rank | 13 | ||||||||||
PB Ratio (x) | 4.03 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 1.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 718.25 | ||||||||||
52W H/L (₹) |
1 Day | 4.44% |
1 Week | 2.82% |
1 Month | 14.09% |
3 Months | 7.61% |
1 Year | 36.56% |
3 Years | 71.72% |
5 Years | N.A. |
Current
Mean Recos by 3 Analysts
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 3 | 3 | 3 | 3 |
Employee & Interest Expense
Company has spent 1.27% of its operating revenues towards interest expenses and 9.28% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)Quarterly | Annual | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|---|
Total Income | 1,066.20 | 1,055.70 | 1,033.91 | 1,083.94 | 975.18 |
Total Income Growth (%) | 0.99 | 2.11 | -4.62 | 11.15 | -5.18 |
Total Expenses | 958.24 | 960.41 | 953.69 | 1,018.92 | 905.07 |
Total Expenses Growth (%) | -0.23 | 0.70 | -6.40 | 12.58 | -3.32 |
EBIT | 107.96 | 95.29 | 80.22 | 65.02 | 70.11 |
EBIT Growth (%) | 13.30 | 18.79 | 23.38 | -7.26 | -24.02 |
Profit after Tax (PAT) | 69.38 | 59.00 | 48.74 | 29.25 | 38.56 |
PAT Growth (%) | 17.59 | 21.05 | 66.63 | -24.14 | -32.93 |
EBIT Margin (%) | 10.13 | 9.03 | 7.76 | 6.00 | 7.19 |
Net Profit Margin (%) | 6.51 | 5.59 | 4.71 | 2.70 | 3.95 |
Basic EPS (₹) | 4.39 | 3.73 | 3.08 | 1.85 | 2.44 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Total Assets | 4,731.89 | 4,258.88 | 3,797.15 | 3,378.52 |
Total Assets Growth (%) | 11.11 | 12.16 | 12.39 | 0.68 |
Total Liabilities | 1,994.42 | 1,592.65 | 1,364.03 | 1,455.58 |
Total Liabilities Growth (%) | 25.23 | 16.76 | -6.29 | - |
Total Equity | 2,737.47 | 2,666.23 | 2,433.12 | 1,922.94 |
Total Equity Growth (%) | 2.67 | 9.58 | 26.53 | - |
Current Ratio (x) | 1.38 | 1.54 | 1.68 | 1.59 |
Total Debt to Equity (x) | 0.27 | 0.15 | 0.09 | 0.24 |
Contingent Liabilities | 491.64 | 746.67 | 437.30 | 347.97 |
All figures in Rs Cr, unless mentioned otherwise
Increase in Cash from Investing
Company has used Rs 568.78 cr for investing activities which is an YoY increase of 20.53%. (Source: Consolidated Financials)Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Net Cash flow from Operating Activities | 429.98 | 462.46 | 452.74 | 112.28 |
Net Cash used in Investing Activities | -568.78 | -471.89 | -71.86 | -43.66 |
Net Cash flow from Financing Activities | 144.13 | 41.60 | -417.75 | -72.37 |
Net Cash Flow | 6.06 | 35.12 | -35.73 | 73.29 |
Closing Cash & Cash Equivalent | 78.78 | 72.73 | 37.61 | 73.34 |
Closing Cash & Cash Equivalent Growth (%) | 8.33 | 93.38 | -48.72 | 0.01 |
Total Debt/ CFO (x) | 1.70 | 0.86 | 0.51 | 4.06 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Return on Equity (%) | 6.68 | 11.53 | 19.59 | 2.82 |
Return on Capital Employed (%) | 9.29 | 14.88 | 26.96 | 3.93 |
Return on Assets (%) | 3.86 | 7.22 | 12.55 | 1.60 |
Interest Coverage Ratio (x) | 8.67 | 26.90 | 27.91 | 13.33 |
Asset Turnover Ratio (x) | 0.92 | 1.16 | 1.38 | 20.24 |
Price to Earnings (x) | 39.06 | 18.62 | 15.02 | 76.92 |
Price to Book (x) | 2.61 | 2.15 | 2.94 | 2.16 |
EV/EBITDA (x) | 17.07 | 10.39 | 8.49 | 37.57 |
EBITDA Margin (%) | 11.03 | 12.16 | 17.44 | 17.50 |
Bullish / Bearish signals for Jubilant Ingrevia basis selected technical indicators and moving average crossovers.
5 Day EMA Crossover
Bullish signal on daily chart
Appeared on: 9 May 2025
5D EMA: 687.93
Date | 7 days Gain/Loss % |
---|---|
2 May 2025 | 4.69% |
11 Apr 2025 | 7.64% |
3 Apr 2025 | 0.34% |
18 Mar 2025 | 5.19% |
Average price gain of 4.70% within 7 days of Bullish signal in last 5 years
Heikin-Ashi Changeover
Bearish indication on daily chart
Prev. Close Price
679.23
LTP
723.70
On daily price chart, Heikin-Ashi candle changed from Green to Red
R1 | R2 | R3 | PIVOT | S1 | S2 | S3 | |
---|---|---|---|---|---|---|---|
Classic | 711.60 | 730.25 | 774.80 | 685.70 | 667.05 | 641.15 | 596.60 |
5 DAYS | 14 DAYS | 28 DAYS | |
---|---|---|---|
ATR | 36.98 | 35.60 | 35.17 |
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of 64.42% as compared to Nifty Midcap 100 which gave a return of 93.2%. (as of last trading session)Choose from Peers
Choose from Stocks
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of 64.42% as compared to Nifty Midcap 100 which gave a return of 93.2%. (as of last trading session)MF Ownership details are not available.
Meeting Date | Announced on | Purpose | Details |
---|---|---|---|
May 13, 2025 | Apr 28, 2025 | Board Meeting | Audited Results & Final Dividend |
Jan 28, 2025 | Jan 20, 2025 | Board Meeting | Quarterly Results & Interim Dividend |
Jan 23, 2025 | Dec 20, 2024 | POM | - |
Oct 22, 2024 | Oct 11, 2024 | Board Meeting | Quarterly Results |
Aug 30, 2024 | Aug 12, 2024 | AGM | - |
Type | Dividend | Dividend per Share | Ex-Dividend Date | Announced on |
---|---|---|---|---|
Interim | 250% | 2.5 | Feb 03, 2025 | Jan 28, 2025 |
Final | 250% | 2.5 | Aug 02, 2024 | May 14, 2024 |
Interim | 250% | 2.5 | Feb 09, 2024 | Jan 30, 2024 |
Final | 250% | 2.5 | Aug 10, 2023 | May 16, 2023 |
Interim | 250% | 2.5 | Feb 10, 2023 | Jan 31, 2023 |
No other corporate actions details are available.
Jubilant Ingrevia Ltd., incorporated in the year 2019, is a Small Cap company (having a market cap of Rs 11,037.39 Crore) operating in Chemicals sector. Jubilant Ingrevia Ltd. key Products/Revenue Segments include Other Operating Revenue and Sale of services for the year ending 31-Mar-2024. Show More
Hari S Bhartia
Co-Chairman & WholeTime DirectorShyam S Bhartia
ChairmanDeepak Jain
Managing Director & CEOChandan Singh
Co-CEO & Whole Time DirectorIndustry
Key Indices Listed on
Nifty 500, BSE 500, BSE 250 SmallCap Index, + 10 more
Address
Bhartiagram,Gajraula,Amroha District, Uttar Pradesh - 244223
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.